World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
12703
World Ranking
3423
National Ranking
143

Paul U. Cameron publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul U. Cameron sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 192 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul U. Cameron D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul U. Cameron sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul U. Cameron is affiliated with the University of Melbourne in Australia. Their research focuses largely on immunology and microbiology, as well as medicine, with a significant emphasis on HIV research and treatment.

The main topics covered in their work include:

  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • T-cell and B-cell Immunology
  • Immunodeficiency and Autoimmune Disorders
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment

Cameron has published in several scientific venues repeatedly, including:

  • PLoS Pathogens
  • The Journal of Immunology
  • Journal of Virus Eradication
  • Cell Reports Medicine
  • Orthopaedics and Trauma

Selected recent papers authored or co-authored by Paul U. Cameron include:

  • "Combination Immune Checkpoint Blockade to Reverse HIV Latency," 2020, The Journal of Immunology
  • "Diverse effects of interferon alpha on the establishment and reversal of HIV latency," 2020, PLoS Pathogens
  • "Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART," 2021, PLoS Pathogens
  • "Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency," 2022, Cell Reports Medicine
  • "Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy," 2021, The Journal of Immunology

Frequent co-authors of Paul U. Cameron include:

  • Sharon R. Lewin
  • Judy Chang
  • Rachel D. Pascoe
  • Vanessa A. Evans
  • Ashanti Dantanarayana

Their research subfields encompass:

  • Immunology
  • Virology
  • Epidemiology
  • Surgery
  • Emergency Medicine

Through these various domains, Cameron contributes to advancing understanding of HIV persistence mechanisms, immune checkpoint pathways, and the interaction of immune cells in the context of HIV infection and treatment. Their body of work highlights intersections between clinical immunology and virology geared toward addressing latent viral reservoirs and improving immune-mediated therapies.

Best Publications

  • Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

    Paul U. Cameron;Peter S. Freudenthal;Jeanne M. Barker;Stuart Gezelter

  • Diversity of receptors binding HIV on dendritic cell subsets

    Stuart G. Turville;Paul U. Cameron;Amanda Handley;George Lin

  • CONJUGATES OF DENDRITIC CELLS AND MEMORY T LYMPHOCYTES FROM SKIN FACILITATE PRODUCTIVE INFECTION WITH HIV-1

    M. Pope;M.G.H. Betjes;N. Romani;H. Hirmand

  • Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

    Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim

  • Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells

    Stuart G. Turville;John J. Santos;Ines Frank;Paul U. Cameron

  • Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium.

    Una O'Doherty;Ralph M. Steinman;Michael Peng;Paul U. Cameron

  • The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo.

    Philip Ellery;Philip Ellery;Emma Dawn Tippett;Emma Dawn Tippett;Ya-Lin Chiu;Geza Paukovics

  • Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

    Annalise M Martin;David Nolan;Ian James;Paul Cameron

  • Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.

    Paul U. Cameron;Suha Saleh;Georgina Sallmann;Ajantha Solomon

  • IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling

    Shuo Li;Marie-Paule Lefranc;John J. Miles;John J. Miles;John J. Miles;Eltaf Alamyar

  • CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency.

    Suha Saleh;Ajantha Solomon;Fiona Wightman;Miranda Xhilaga

  • The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.

    Claire E Hirst;Marguerite Stella Buzza;Catherina Hedwig Bird;Hilary S Warren

  • HIV-1 selection by epidermal dendritic cells during transmission across human skin.

    Jeanette C. Reece;Amanda J. Handley;E. John Anstee;Wayne A. Morrison

  • The role of dendritic cell C-type lectin receptors in HIV pathogenesis

    Stuart Turville;John Wilkinson;Paul Cameron;Joanne Dable

  • Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency

    Vanessa A. Evans;Renée M. Van Der Sluis;Ajantha Solomon;Ashanti Dantanarayana

  • Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging

    Edwin Leeansyah;Paul U. Cameron;Paul U. Cameron;Ajantha Solomon;Ajantha Solomon;Surekha Tennakoon;Surekha Tennakoon

  • Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor κB ligand (RANKL)

    Geoffrey C. Nicholson;Mary Malakellis;Fiona M. Collier;Paul U. Cameron

  • Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.

    Emma Tippett;Emma Tippett;Wan-Jung Cheng;Clare Westhorpe;Paul U. Cameron;Paul U. Cameron;Paul U. Cameron

  • Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation

    Gregor F Lichtfuss;Wan-Jung Cheng;Yagmur Farsakoglu;Yagmur Farsakoglu;Geza Paukovics

  • Dendritic cells and the replication of HIV-1.

    P Cameron;M Pope;A Granelli-Piperno;R M Steinman

Frequent Co-Authors

Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Suzanne M. Crowe
Suzanne M. Crowe Burnet Institute
Simon Mallal
Simon Mallal Vanderbilt University Medical Center
Anthony Jaworowski
Anthony Jaworowski RMIT University
Anthony L. Cunningham
Anthony L. Cunningham University of Sydney
Paul R. Gorry
Paul R. Gorry RMIT University
Stephen J. Kent
Stephen J. Kent University of Melbourne
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Ian James
Ian James Perron Institute for Neurological and Translational Science
Monica A. Slavin
Monica A. Slavin Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals transition into advanced practice roles, such as Nurse Practitioners (NPs), which often require specialized education pathways. For example, an fnp to acnp bridge program online allows Family Nurse Practitioners to gain acute care expertise efficiently, broadening their clinical scope.

Additionally, accelerated nursing degrees provide a fast track for those with prior degrees seeking to enter nursing practice quickly. Prospective students should consider the best accelerated nurse practitioner online programs to balance rigor with flexibility for busy schedules.

For individuals without a nursing background, starting with online bsn programs for non nurses can be an accessible entry point into the healthcare field, laying a foundation for further specialization in immunology-related areas.

Salary prospects are another important factor. Understanding the dnp salary by state helps professionals make informed decisions about education investments and career moves within the dynamic healthcare environment.

Best Scientists Citing Paul U. Cameron

Trending Scientists